Cure Genetics
PrivateLast Round
Series B
Jan 5, 2022
Total Funding Raised
$79.2M
Company Overview
Cure Genetics is a biotechnology company that develops cell and gene therapies for solid tumors and genetic diseases using its proprietary AIMS CAR-NKT and VELP AAV platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cure Genetics Comparables
Compare Cure Genetics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EdiGene | 81% | |
| ImmunoKite Therapeutics | 77% | |
| Metagenomi | 76% |
Cure Genetics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 5, 2022 | ||||
| Series A | Aug 6, 2018 | ||||
| Angel | Jan 1, 2017 |
Key People
Founding team and executive leadership
Cure Genetics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Series B |
| Blue Ocean Capital Group | Series B |
| Advantech Capital | Series B |
| Qiming Venture Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 6, 2018
$17M round led by Qiming Venture Partners
Cure Genetics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cure Genetics's valuation, stock price, and market status.
Is Cure Genetics a public or private company?
Cure Genetics is a private company.
What is the current stock price of Cure Genetics?
Cure Genetics is a private company with no public stock price. No recent secondary market data is available.
How much is Cure Genetics worth (valuation)?
Valuation information for Cure Genetics is not publicly available.
Can I buy Cure Genetics stock?
Cure Genetics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cure Genetics's last funding round?
Cure Genetics's most recent funding round was Series B on January 5, 2022.
Who are the main investors in Cure Genetics?
Key investors in Cure Genetics include Advantech Capital, Qiming Venture Partners.
Will Cure Genetics IPO soon?
No public IPO plans have been announced for Cure Genetics.
How can I track Cure Genetics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cure Genetics's secondary market activity and sign up for updates.